By Charles Alovisetti and Ilya Ross
Feb 19, 2021
With wary investors and a minimal number of FDIC-insured bank lenders in the space, cannabis entrepreneurs are running out of options to raise capital. SPACs create a unique opportunity to fill the current vacuum of capital in the cannabis industry.
By Michelle Bodian
Feb 10, 2021
With state legislative sessions in full swing, plenty of hemp and CBD bills have been filed across the country.
By Jennifer Cabrera, Andrea Golan, Brandon Kurtzman, Jerrico Perez
Feb 3, 2021
Regulatory agencies can deny cannabis license applications for various reasons, but a denied application is not the end of the line.
By Andrea A. Golan, Michelle Bodian
Jan 28, 2021
Cannabis businesses are not eligible for relief under any of the federal COVID-19 aid packages, but members of Congress and industry groups are making significant efforts to include cannabis businesses in federal aid.
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.